“…In their first randomized double blinded placebo controlled trial for CeD patients, infection with hookworm did not protect against a five day oral wheat challenge equivalent to 16 g of gluten per day [3]. However, they then embarked on a second study with an important modification [4]. This time, after hookworm infection was established, CeD patients were ‘tolerized’ with gluten microchallenges (escalating from 10 mg), before being challenged with 3 g daily for 2 weeks [4].…”
There is growing interest in treating inflammatory conditions with helminth infection. Recently, Loukas and colleagues have reported promising results from using experimental hookworm infection to reduce gluten sensitivity in celiac disease patients. Analysis of microbiota samples from the trial is contributing to our understanding of the complexity underlying helminth-microbiota-host relationships.
“…In their first randomized double blinded placebo controlled trial for CeD patients, infection with hookworm did not protect against a five day oral wheat challenge equivalent to 16 g of gluten per day [3]. However, they then embarked on a second study with an important modification [4]. This time, after hookworm infection was established, CeD patients were ‘tolerized’ with gluten microchallenges (escalating from 10 mg), before being challenged with 3 g daily for 2 weeks [4].…”
There is growing interest in treating inflammatory conditions with helminth infection. Recently, Loukas and colleagues have reported promising results from using experimental hookworm infection to reduce gluten sensitivity in celiac disease patients. Analysis of microbiota samples from the trial is contributing to our understanding of the complexity underlying helminth-microbiota-host relationships.
“…Finally, several immune modulatory strategies have been advanced for CD treatment, from anti-interleukin (IL)-15 antibodies for refractory CD patients to drugs blocking deamidation or presentation of gliadin peptides to T cells. Importantly, efforts have been made to develop a definitive cure for CD by a peptide-based vaccination strategy [7] or suppression of the inflammatory immune response with hookworm infections [8]. The restoration of tolerance toward orally ingested gluten is currently the only approach that might lead to a cure, rather than treatment, of the disease.…”
“…Bu çalışmaların hiçbirinde patolojinin önemli derecede etkilendiği gözlene-memesine rağmen, çölyak hastalığı odaklı başka bir çalışmada, T H 1/T H 17 immün yanıtının T H 2 ve IL-10 yolaklarıyla baskılandığı rapor edilmiş-tir [104] . Bunun yanında, Necator americanus ve fazla miktarda glutenin birlikte uygulanmasının toleransı artırdığı, gluten toksisitesi ile ilişkili belirtileri stabilize ettiği/geliştirdiği ve T H 1 hücre sayısını azaltırken T reg düzeyini yükselttiği gösteril-miştir [105] . Bu çelişkili sonuçlardan dolayı, kancalı kurt infeksiyonlarının insan immünopatolojilerinin tedavisinde uygulanabilir bir seçenek olup olmadığı hala tartışma konusudur [2] .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.